Many of Australia's top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.
Three buy ratings that have caught my eye are summarised below. Here's why brokers think these ASX shares are in the buy zone:
BHP Group Ltd (ASX: BHP)
According to a note out of Goldman Sachs, its analysts have upgraded this mining giant's shares to a buy rating with a $41.90 price target after reviewing its five key greenfield oil projects. Goldman believes that these projects could boost the company's oil production by 50% to 180 Mmboe by FY 2030. In addition to this, the broker continues to expect iron ore prices to stay higher for longer due to a potential deficit in 2020. It believes restocking from Chinese steel mills will drive iron ore back to beyond US$100 a tonne during the fourth quarter. I agree with Goldman on BHP and feel it would be a great option for investors looking for exposure to the resources sector.
Ramsay Health Care Limited (ASX: RHC)
A note out of Citi reveals that its analysts have upgraded this private hospital operator's shares to a buy rating with a $74.00 price target. According to the note, although the broker notes that the Australian market is still facing a number of headwinds, it expects Ramsay to benefit from market share gains. In addition to this, it sees a lot of positives in the recent Capio acquisition and appears confident that it will support its growth in FY 2020. Whilst I think Ramsay is a high quality company, I'm holding off an investment until trading conditions improve.
Syrah Resources Ltd (ASX: SYR)
Analysts at Credit Suisse have held firm with their outperform rating but trimmed the price target on this graphite producer's shares to $2.30 following its recent production downgrade. According to the note, whilst the decline in graphite prices is disappointing and appears to have been driven partly by increased supply in China, the broker remains optimistic on the long term due to its bullish view on demand for lithium-ion battery technology. Whilst I think that Credit Suisse makes a fair point, I would suggest investors wait for graphite prices to rebound materially before considering an investment.
